Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/1997
1.
Phase II Study of Combination Chemotherapy with DOX/VP-16 plus Quinidine in Patients with Unresectable Colorectal Cancer (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
16 and over
NCI
NCI-88-C-113
NCI-MB-221, NCI-T88-0173N, T88-0173
Last Modified:
9/1/1990
2.
Phase II Study of MDR-1 Expression and Pharmacologic Reversal in Patients with Recurrent Breast Cancer Treated with Doxorubicin and Amiodarone (Summary Last Modified 09/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
20 to 80
NCI
NCI-88-C-188B
NCI-MB-228, NCI-T88-0227N, T88-0227
Last Modified:
6/1/1989
3.
Phase II Study of DOX with or without Quinidine Sulfate, Depending on Tumor Cell mdr-1 Gene Expression, in Patients with Recurrent Metastatic Colorectal Carcinoma (Summary Last Modified 06/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
MAOP-5187
NCI-V89-0036
Last Modified:
5/3/2007
4.
Phase II Study of VP-16 plus Chemotherapy Resistance Modulators in the Treatment of VP-16-Resistant Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-OTT-9008
NCI-V91-0084
Last Modified:
2/1/1990
5.
Phase I Study of VBL plus Quinidine in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 02/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
PCI-8817
NCI-V89-0314
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute